Elevated Plasma CXCL8 Concentrations in Significant Fibrosis but Not in Subclinical Rejection After Adult Liver Transplantation
Open Access
- 21 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (3) , e1592
Abstract
Background.: The noninvasive detection of subclinical graft injury including subclinical T cell–mediated rejection (subTCMR) is one of the unresolved challenges after liver transplantation. Recently, serum C-X-C motif chemokine ligand 8 (CXCL8) was proposed as a highly accurate marker of subTCMR in pediatric liver transplant recipients. We aimed to evaluate the accuracy of the quantification of this chemokine for predicting subTCMR in adult liver transplant recipients, as well as its capacity to classify patients who could benefit from immunosuppression reduction. Methods.: Plasma CXCL8 concentrations were measured retrospectively in a prospectively collected cohort of adult liver transplant recipients with well-characterized histologic phenotypes. Results.: In total, 78 patients were included. Median plasma CXCL8 concentrations did not differ (P = 0.24) between patients without histological evidence of rejection (3.6 [0.4–22.0] pg/mL), subTCMR (11.5 [0.4–41.0] pg/mL), clinical TCMR (9.4 [0.4–40.5] pg/mL), and other etiologies of graft injury (8.7 [0.4–31.2] pg/mL). Likewise, plasma CXCL8 concentrations did not discriminate between patients within and outside histologic criteria for immunosuppression reduction that were proposed by the 2016 Banff Working Group on Liver Allograft Pathology (cutoff: 10.9 pg/mL, sensitivity: 0.48, and specificity: 0.79). Furthermore, weak correlation was found between plasma CXCL8 and alanine aminotransferase and aspartate aminotransferase (Spearman ρ = 0.18 and 0.25). Patients with significant fibrosis (17.8 [0.4–40.5] pg/mL) showed higher plasma CXCL8 concentrations than patients without fibrosis (8.2 [0.4–41.0] pg/mL; P = 0.05). Conclusions.: Plasma CXCL8 concentrations are not predictive of subclinical graft injury or of histological criteria for the minimization of immunosuppression in adult liver transplant recipients.Keywords
This publication has 24 references indexed in Scilit:
- 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated RejectionAmerican Journal of Transplantation, 2016
- Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allograftsLiver Transplantation, 2016
- Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal RangesArchivum Immunologiae et Therapiae Experimentalis, 2015
- Diagnostic value of interleukin-8 in colorectal cancer: A case-control study and meta-analysisWorld Journal of Gastroenterology, 2014
- Novel Histologic Scoring System for Long-Term Allograft Fibrosis After Liver Transplantation in ChildrenAmerican Journal of Transplantation, 2012
- Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver FibrosisPLOS ONE, 2011
- The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8Journal of Hepatology, 2010
- CORTICOSTEROIDS AND INTERFERONS INHIBIT CYTOKINE-INDUCED PRODUCTION OF IL-8 BY HUMAN ENDOTHELIAL CELLSCytokine, 2000
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- INTERLEUKIN-8 SERUM CONCENTRATIONS AFTER LIVER TRANSPLANTATIONTransplantation, 1992